EDITAS MEDICINE INC's ticker is EDIT and the CUSIP is 28106W103. A total of 304 filers reported holding EDITAS MEDICINE INC in Q4 2021. The put-call ratio across all filers is 3.56 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $156 | -5.5% | 20 | 0.0% | 0.00% | – |
| Q2 2023 | $165 | +13.8% | 20 | 0.0% | 0.00% | – |
| Q1 2023 | $145 | -18.1% | 20 | 0.0% | 0.00% | – |
| Q4 2022 | $177 | – | 20 | 0.0% | 0.00% | – |
| Q3 2022 | $0 | – | 20 | 0.0% | 0.00% | – |
| Q2 2022 | $0 | -100.0% | 20 | -88.2% | 0.00% | – |
| Q1 2022 | $3,000 | -40.0% | 170 | 0.0% | 0.00% | -100.0% |
| Q4 2021 | $5,000 | -54.5% | 170 | -37.0% | 0.00% | 0.0% |
| Q3 2021 | $11,000 | -26.7% | 270 | 0.0% | 0.00% | -50.0% |
| Q2 2021 | $15,000 | +36.4% | 270 | 0.0% | 0.00% | 0.0% |
| Q1 2021 | $11,000 | -42.1% | 270 | 0.0% | 0.00% | -33.3% |
| Q4 2020 | $19,000 | +171.4% | 270 | +8.0% | 0.00% | +200.0% |
| Q3 2020 | $7,000 | -86.5% | 250 | -85.7% | 0.00% | -90.9% |
| Q2 2020 | $52,000 | +48.6% | 1,754 | 0.0% | 0.01% | +22.2% |
| Q1 2020 | $35,000 | -66.7% | 1,754 | -50.6% | 0.01% | -62.5% |
| Q4 2019 | $105,000 | – | 3,554 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| NIA IMPACT ADVISORS, LLC | 54,615 | $4,897,000 | 2.55% |
| Capital Impact Advisors, LLC | 130,000 | $9,114,000 | 2.24% |
| ARK Investment Management | 10,125,564 | $709,903,000 | 1.89% |
| Nikko Asset Management Americas, Inc. | 4,388,143 | $307,653,000 | 1.75% |
| Spectrum Planning & Advisory Services Inc. | 17,522 | $1,228,000 | 1.32% |
| DDD Partners, LLC | 79,527 | $5,576,000 | 1.10% |
| Brevan Howard Capital Management LP | 76,420 | $5,358,000 | 1.08% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 538,721 | $37,770,000 | 0.75% |
| DC Investments Management, LLC | 3,627 | $254,000 | 0.63% |
| Haafor (Singapore) Pte. Ltd. | 4,761 | $334,000 | 0.62% |